复星医药

- 600196

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
复星医药(600196) 利润表
单位:万元
报表日期2014-12-312014-09-302014-06-302014-03-31
一、营业总收入1,202,553.20866,144.46553,853.93265,782.97
营业收入1,202,553.20866,144.46553,853.93265,782.97
二、营业总成本1,154,549.47803,381.03519,266.20252,044.53
营业成本671,856.88490,548.80318,661.63155,506.99
营业税金及附加8,728.955,988.313,631.531,676.70
销售费用230,042.37160,679.23101,729.7650,283.12
管理费用172,681.89119,883.8678,141.3637,172.53
财务费用37,878.6325,102.4215,967.637,283.16
研发费用--------
资产减值损失33,360.741,178.401,134.29122.03
公允价值变动收益-1,070.20-951.68-598.66154.51
投资收益192,501.15146,290.0299,126.9240,191.46
其中:对联营企业和合营企业的投资收益91,045.0470,186.8048,863.7124,837.05
汇兑收益--------
三、营业利润239,434.68208,101.77133,115.9954,084.41
加:营业外收入34,047.093,851.212,038.37746.87
减:营业外支出1,676.411,553.131,337.62331.25
其中:非流动资产处置损失84.98747.04683.0673.38
四、利润总额271,805.36210,399.85133,816.7554,500.03
减:所得税费用34,821.4730,998.1420,140.856,211.97
五、净利润236,983.89179,401.71113,675.9048,288.05
归属于母公司所有者的净利润211,286.95157,458.39100,201.4641,391.98
少数股东损益25,696.9521,943.3213,474.446,896.07
六、每股收益
基本每股收益(元/股)0.92000.69000.44000.1800
稀释每股收益(元/股)0.92000.69000.44000.1800
七、其他综合收益-6,768.9114,605.72-2,432.60-6,410.98
八、综合收益总额230,214.98194,007.43111,243.2941,877.07
归属于母公司所有者的综合收益总额205,133.81172,239.2198,008.4335,151.51
归属于少数股东的综合收益总额25,081.1721,768.2213,234.876,725.56
下载全部历史数据到excel中 返回页顶